SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...
"6 in '26" expected proof-of-concept (POC) readouts across SKYLINE and SKYWAY trials SKYLINE platform trial in ulcerative colitis (UC) recruiting faster than expected with SPY001 enrollment complete ...
Activists said the number of people killed rise to at least 544 on Monday, as the Islamic Republic continued its bloody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback